Test Price
2,800 AED✅ Home Collection Available
CLP1 Gene Pontocerebellar Hypoplasia Type 10 Genetic Testing | 2,800 AED
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Accredited Next‑Generation Sequencing (NGS), validated by our CAP‑aligned laboratory.
Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic Post‑Test Clinical Guidance by DHA‑licensed Consultant Medical Geneticist to interpret results.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The CLP1 gene test utilises Next‑Generation Sequencing (NGS) to detect pathogenic variants associated with pontocerebellar hypoplasia type 10, a severe autosomal recessive neurodegenerative disorder. This analysis provides molecular confirmation for clinical diagnosis, family risk assessment, and reproductive planning.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Methodology | NGS (Next‑Generation Sequencing) – full gene | Targeted single‑variant PCR |
| Sensitivity | >99.9% for point mutations & small indels | Limited to known familial variant only |
| Turnaround Time | 3–4 weeks (delivered via secure portal) | 4–6 weeks with possible send‑out delays |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics at DNA Labs UAE, I emphasise that the CLP1 gene test provides critical diagnostic information for pontocerebellar hypoplasia type 10. Genetic counselling is mandatory before and after testing to avoid misinterpretation and ensure informed decision‑making.”
— Ms. Lina Osama Zaki Quteineh, DHA Registration ID: 9294403
Advisory & Medication Safety
Do not discontinue any prescribed medication without consulting your treating physician. Genetic test results do not replace ongoing neurological management or any current treatment plan.
Exclusion Criteria & Emergency Red Flags
- Individuals who decline pre‑test genetic counselling.
- Minors without legal guardian consent (per Federal Decree‑Law No. 4 of 2016 on Medical Liability).
- Patients with uncorrected severe coagulopathy unless medically cleared.
- Seek emergency care if you experience sudden loss of consciousness, respiratory distress, or prolonged seizures during the testing period.
Patient FAQ & Clinical Guidance
1. What is the CLP1 gene and why test for pontocerebellar hypoplasia type 10?
The CLP1 gene analysis provides definitive molecular diagnosis for pontocerebellar hypoplasia type 10, aiding clinical management and family planning. It is recommended when MRI brain shows characteristic pontocerebellar hypoplasia or when there is a positive family history, and the result can differentiate this type from other PCH subtypes.
2. How is the sample collected for this genetic test in the UAE?
A simple blood draw or a single drop of blood on an FTA card is collected at your home by our DHA‑licensed phlebotomist; the sample is transported in a certified cold‑chain system. No special fasting or medication adjustments are needed unless instructed otherwise.
3. How long does it take to receive the results?
Results are delivered within 3 to 4 weeks via secure encrypted report and include complimentary post‑test clinical guidance by a Consultant Medical Geneticist. A genetic counselling session is arranged upon patient request to explain the findings and implications.
UAE Regulatory & Data Privacy Adherence
- All clinical data handling complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Patient consent is obtained in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- All testing performed under ISO 9001:2015 certified facility (Cert: INT/EGQ/2509DA/3139).
- Results are transmitted via end‑to‑end encrypted digital platform.
Clinical & Logistical Metadata
| Test Name | CLP1 Gene Sequencing for Pontocerebellar Hypoplasia Type 10 |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA), or single drop on FTA card |
| Methodology Used | Next‑Generation Sequencing (NGS) |
| ICD-10-CM Code | G31.89 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians